NANOMETRICS INC
10-Q, 1996-08-06
MEASURING & CONTROLLING DEVICES, NEC
Previous: SOUTHERN BANCSHARES NC INC, 10-Q, 1996-08-06
Next: MERRIMAC INDUSTRIES INC, S-8, 1996-08-06





                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549

                                    FORM 10-Q


     X  Quarterly  report  pursuant  to  Section  13 or 15(d) of the  Securities
   ---- Exchange Act of 1934


For the quarterly period ended June  30,  1996
                               ---------------

        Transition  report  pursuant  to Section  13 or 15(d) of the  Securities
        Exchange Act of 1934

For the transition period from _______________ to _______________

Commission file number                   0-13470
                       ------------------------------------------


                           NANOMETRICS INCORPORATED
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)


              California                                         94-2276314
   -------------------------------                           ------------------
   (State or other jurisdiction of                           (I. R. S. Employer
    incorporation or organization)                           Identification No.)


   310 DeGuigne Drive, Sunnyvale, CA                                94086
- ---------------------------------------                           ---------
(Address of principal executive offices)                          (Zip Code)


Registrant's telephone number, including area code      (408) 746-1600
                                                   ------------------------   

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed  by  Section  13 or 15 (d) of the  Securities  Exchange  Act of 1934
during the preceding 12 months (or for such shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past 90 days.

                           YES    X        NO
                                 ---            ---

At July 12, 1996 there were 8,068,672 shares of common stock, no par value,
issued and outstanding.


<PAGE>

                            NANOMETRICS INCORPORATED

                                      INDEX


Part I.  Financial Information                                              Page
                                                                            ----
     Item 1. Financial Statements

             Consolidated Balance Sheets - 
             June 30, 1996 and December 31, 1995 . . . . . . . . . . . . . . . 3
             
             Consolidated Statements  of Income -
             Three months and six months ended 
             June 30, 1996 and 1995. . . . . . . . . . . . . . . . . . . . . . 5

             Consolidated Statements of Cash Flows -
             Six months ended June 30, 1996
             and  1995 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

             Notes to Consolidated Financial
             Statements  .  .  .  . . . . . . . . . . . . . . . . . . . . . . .7

     Item 2. Management's Discussion and Analysis of
             Financial  Condition  and Results of  Operations . . . . . . . . .8



Part II. Other Information

     Item 4. Submission  of  Matters to a Vote of  Security  Holders  . . . . 10


     Item 6. Exhibits  and  Reports on Form 8-K . . . . . . . . . . . . . . . 10



Signatures  .  .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11




                                       2


<PAGE>


PART I:  FINANCIAL INFORMATION

ITEM 1:  FINANCIAL STATEMENTS




                            NANOMETRICS INCORPORATED
                           CONSOLIDATED BALANCE SHEETS
                   (Amounts in thousands except share amounts)
                                   (Unaudited)

                                     ASSETS

                                                        June 30,    December 31,
                                                          1996          1995
                                                       ---------    ------------
Current assets:
   Cash and equivalents ............................    $ 1,680       $ 3,625
   Short-term investments ..........................      6,072         4,458
   Accounts receivable, less allowance for
     doubtful accounts of $378 and $380 ............     10,598         7,567
   Inventories .....................................      4,976         3,955
   Prepaid and deferred income taxes ...............      1,600         2,069
    Prepaid expenses and other .....................        550           428
                                                        -------       -------

Total current assets ...............................     25,476        22,102

Property, plant and equipment, net .................      2,645         2,900
Other assets .......................................        187           165
                                                        -------       -------

                                                        $28,308       $25,167
                                                        =======       =======


                 See Notes to Consolidated Financial Statements

                                       3

<PAGE>


                            NANOMETRICS INCORPORATED
                           CONSOLIDATED BALANCE SHEETS
                                   (Continued)
                   (Amounts in thousands except share amounts)
                                   (Unaudited)

                      LIABILITIES AND SHAREHOLDERS' EQUITY

                                                         June 30,   December 31,
                                                           1996         1995
                                                         -------    ------------
Current liabilities:                                               
  Accounts payable .................................     $ 1,487          $1,111
  Accrued payroll and related expenses .............         711             486
  Other current liabilities ........................       1,871           1,216
  Income taxes payable .............................         677             398
  Current portion of long-term debt ................         365             553
                                                         -------         -------
                                                                   
     Total current liablities ......................       5,111           3,764
                                                                   
Long-term debt .....................................       3,646           3,528
                                                                   
Deferred income taxes ..............................         196             301
                                                         -------         -------
                                                                   
     Total liabilities .............................       8,953           7,593
                                                         -------         -------
                                                                   
Shareholders' equity:                                              
  Common stock, no par value;                                      
    25,000,000 shares authorized                                   
    8,065,339 and 7,883,910 outstanding ............      11,156          10,983
  Retained earnings ................................       8,189           6,394
  Accumulated translation adjustment ...............          10             197
                                                         -------         -------
                                                                   
     Total shareholders' equity ....................      19,355          17,574
                                                         -------         -------
                                                                   
                                                         $28,308         $25,167
                                                         =======         =======
                                                                  

                 See Notes to Consolidated Financial Statements


                                       4
<PAGE>

<TABLE>

                            NANOMETRICS INCORPORATED
                        CONSOLIDATED STATEMENTS OF INCOME
                (Amounts in thousands, except per share amounts)
                                   (Unaudited)
<CAPTION>

                                                                        Three Months Ended                      Six Months Ended
                                                                              June 30,                               June 30,
                                                                     1996                1995               1996              1995
                                                                   --------            -------            -------            -------
<S>                                                                 <C>                <C>                <C>                <C>    
Revenues:
    Net sales ..........................................            $ 5,991            $ 3,947            $11,545            $ 7,556
    Service ............................................              1,566              1,257              3,080              2,190
                                                                    -------            -------            -------            -------
         Total revenues ................................              7,557              5,204             14,625              9,746

Costs and expenses:
    Cost of sales ......................................              2,533              1,831              4,902              3,581
    Cost of service ....................................              1,045                810              2,048              1,554
    Research and development ...........................                665                684              1,335              1,189
    Selling ............................................              1,255                872              2,266              1,624
    General and administrative .........................                582                529              1,152              1,026
                                                                    -------            -------            -------            -------
      Total costs and expenses .........................              6,080              4,726             11,703              8,974
                                                                    -------            -------            -------            -------

Operating income .......................................              1,477                478              2,922                772

Other income,  net .....................................                117                296                189                468
                                                                    -------            -------            -------            -------

Income  before provision
 for  income taxes .....................................              1,594                774              3,111              1,240

Provision for income taxes .............................                633                194              1,316                354
                                                                    -------            -------            -------            -------

Net income .............................................            $   961            $   580            $ 1,795            $   886
                                                                    =======            =======            =======            =======


Net income per common
 and equivalent share ..................................            $   .11            $   .07            $   .21            $   .11
                                                                    =======            =======            =======            =======

Weighted average common and
  equivalent shares outstanding ........................              8,583              8,349              8,567              8,029
                                                                    =======            =======            =======            =======


<FN>

                 See Notes to Consolidated Financial Statements

</FN>
</TABLE>


                                        5
<PAGE>


                            NANOMETRICS INCORPORATED
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                             (Amounts in thousands)
                                   (Unaudited)
                                                              Six Months Ended
                                                                   June 30,
                                                              1996        1995
                                                            -------     --------
Operating activities:
    Net income .........................................    $ 1,795    $    886
    Adjustments to reconcile net income to net cash
    provided by (used in) operating activities:
        Depreciation and amortization ..................        143         157
        Deferred income taxes ..........................        500        (214)
        Changes in assets and liabilities:
           Accounts receivable .........................     (3,164)       (990)
           Inventories .................................     (1,077)        489
           Prepaid expenses and other ..................       (333)       (203)
           Accounts payable and other liabilities ......      1,291         571
           Income taxes payable ........................       (409)        320
                                                            -------     -------
Net cash provided by (used in) operating activities ....     (1,254)      1,016
                                                            -------     -------

Investing activities:
    Purchase of short-term investments .................     (7,603)     (6,714)
    Sales/maturities of short-term investments .........      5,989       1,576
    Capital expenditures ...............................        (32)         (6)
                                                            -------     -------
Net cash used in investing activities ..................     (1,646)     (5,144)
                                                            -------     -------

Financing activities:
    Proceeds from long-term borrowings .................        762       4,700
    Repayments of long-term debt .......................       (594)       (160)
    Issuance of common stock ...........................        786         141
                                                            -------     -------
Net cash provided by financing activities ..............        954       4,681
                                                            -------     -------

Effect of exchange rate changes on cash ................          1        (385)
                                                            -------     -------

Net change in cash and equivalents .....................     (1,945)        168
Cash and equivalents at beginning of period ............      3,625       2,135
                                                            -------     -------
Cash and equivalents at end of period ..................    $ 1,680     $ 2,303
                                                            =======     =======

Supplemental Disclosure of Cash Flow Information:
    Cash paid for interest .............................    $    61     $    35
                                                            =======     =======

    Cash paid for income taxes .........................    $    87     $    23
                                                            =======     =======


                 See Notes to Consolidated Financial Statements

                                       6

<PAGE>


                            NANOMETRICS INCORPORATED
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)


Note 1.        Consolidated Financial Statements

    The consolidated  financial  statements  include the accounts of Nanometrics
Incorporated  and its wholly owned  subsidiaries.  All significant  intercompany
accounts and transactions have been eliminated.

    While the  quarterly  financial  information  is  unaudited,  the  financial
statements  included in this report reflect all adjustments  (consisting only of
normal recurring  adjustments) which the Company considers  necessary for a fair
presentation of the results of operations for the interim periods covered and of
the financial condition of the Company at the date of the interim balance sheet.
The operating results for interim periods are not necessarily  indicative of the
operating  results  that may be expected for the entire  year.  The  information
included  in this  report  should be read in  conjunction  with the  information
included in the Company's  1995 Form 10-K filed with the Securities and Exchange
Commission.

Note 2.        Per Share Information

    Net income per share is based on the weighted  average  number of common and
common equivalent shares outstanding during the period. Common equivalent shares
include dilutive common stock options (using the treasury stock method).

Note 3.        Inventories

    Inventories are stated at the lower of cost (first-in,  first-out) or market
and consist of the following:

                                                     June 30,       December 31,
                                                       1996             1995
                                                     --------       ------------
                                                       (Amounts in thousands)

Raw materials and subassemblies ..................   $1,817            $1,727
Work in process ..................................    2,093               830
Finished goods ...................................    1,066             1,398
                                                     ------            ------
                                                     $4,976            $3,955
                                                     ======            ======
                                                              
Note 4.        Borrowing Arrangements

    In April 1996, the Company borrowed  approximately $762,000 (80,000,000 Yen)
from the Japan Development Bank in Tokyo, Japan to provide  supplemental working
capital for the Company's  operations.  The loan was secured using the Company's
factory and adjacent land in Japan as collateral. This obligation bears interest
at the  rate of 3.4%  and is due in  quarterly  installments  of  principal  and
interest through 2006.

                                       7

<PAGE>



ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
         AND RESULTS OF OPERATIONS


RESULTS OF OPERATIONS

    Total revenues for the three months ended June 30, 1996 were $7,557,000,  an
increase of $2,353,000 or 45% from the  comparable  period in 1995.  For the six
months  ended  June  30,  1996,  total  revenues  of  $14,625,000  increased  by
$4,879,000 or 50% from the  comparable  period in 1995.  Net sales of $5,991,000
and  $11,545,000  for the three  months  and six  months  ended  June 30,  1996,
respectively,  increased $2,044,000 or 52% and $3,989,000 or 53%,  respectively,
as compared  with the same  periods  during  1995.  The  increases  in net sales
resulted  from stronger  demand for, and  increased  shipments of, the Company's
products,  especially its automated products,  from customers in the U.S., Korea
and Japan. Service revenue of $1,566,000 and $3,080,000 for the three months and
six months  ended June 30,  1996,  respectively,  increased  $309,000 or 25% and
$890,000 or 41%,  respectively,  as compared to the same periods in 1995.  These
increases in service  revenue are primarily  attributable  to increased sales of
accessories  and  upgrades in the U.S. and Japan in 1996.  The Company  believes
that its revenue  growth for the three and six month periods ended June 30, 1996
is not necessarily indicative of future results.

    Cost of sales as a percentage of net sales  decreased from 46% in the second
quarter of 1995 to 42% in the second quarter of 1996 primarily because of higher
sales volume resulting in lower per unit manufacturing costs. Cost of service as
a percentage of service revenue increased from 64% in the second quarter of 1995
to 67% in the second quarter of 1996.  This increase was primarily  attributable
to the addition of service  personnel  needed to support the  Company's  growing
sales and installed  base of systems at customer  locations.  Cost of sales as a
percentage of net sales for the six months ended June 30, 1996  decreased to 42%
from 47% a year ago as a result of higher  sales  volume  resulting in lower per
unit manufacturing costs. Cost of service as a percentage of service revenue for
the six months ended June 30, 1996  decreased  to 66% from 71% a year ago.  This
decrease  was  primarily  attributable  to  relatively  higher  margins  on  the
additional sales of accessories in the first quarter of 1996.

    Research and  development  expenses for the three months ended June 30, 1996
decreased $19,000 or 3% compared to the same period in 1995 resulting from lower
material costs  associated with continuing  product  development at the Japanese
subsidiary.  Research and development expenses for the six months ended June 30,
1996 increased $146,000 or 12% compared to the same period in 1995 primarily due
to the addition of software engineers in the U.S.

    Selling  expenses for the three month and six month  periods  ended June 30,
1996 increased by $383,000 or 44% and $642,000 or 40%, respectively, compared to
the same  periods  in 1995  primarily  because  of  higher  commission  expenses
resulting  from higher sales and the  addition of sales  offices and sales staff
during the past 12 months.

    General  and  administrative  expenses  for the  three  month  and six month
periods  ended June 30, 1996  increased  by $53,000 or 10% and  $126,000 or 12%,
respectively,  compared  to the same  periods  in 1995 as a result  of  spending
associated with increased operating activity.

    Other income for the three month and six month  periods  ended June 30, 1996
decreased  $179,000 and $279,000,  respectively,  from the comparable periods in
1995 due to lower exchange rate gains in 1996.

    The Company  reported an operating  income of  $1,477,000  and net income of
$961,000  for the second  quarter of 1996  compared  to an  operating  income of
$478,000 and net income of $580,000  for the same

                                       8


<PAGE>

period in 1995.  For the  first six  months of 1996,  the  Company  reported  an
operating income of $2,922,000 and net income of $1,795,000 which compared to an
operating  income of $772,000  and net income of $886,000 for the same period in
1995.


Liquidity and Capital Resources

    At June 30, 1996, the Company had working capital of $20,365,000 compared to
$18,338,000  at December 31, 1995. The current ratio at June 30, 1996 was 5.0 to
1.  The  Company  believes   working  capital   including  cash  and  short-term
investments of $7,752,000  will be sufficient to meet its needs at least through
the next twelve  months.  Operating  activities for the first six months of 1996
used  cash of  $1,254,000  primarily  from  increased  accounts  receivable  and
inventory, which were offset to some extent by increased accounts payable, while
the  net  purchases  of  short-term   investments   used   $1,614,000,   capital
expenditures  used  $32,000,  a  long-term  loan from a Japanese  bank  provided
$762,000,  debt  repayment  used $594,000 and issuance of common stock  provided
$786,000.


    The foregoing Management  Discussion and Analysis of Financial Condition and
Results of Operations contains forward-looking  statements within the meaning of
Section 27A of the  Securities  Act of 1933,  and Section 21E of the  Securities
Exchange Act of 1934.  These statements  involve risks and  uncertainties as set
forth under  "Management's  Discussion  and Analysis of Financial  Condition and
Results of Operations - Risk Factors" in the 1995 Annual  Report.  The Company's
actual  results could differ  materially  from the results  anticipated  in such
forward-looking statements.

                                       9


<PAGE>


                            NANOMETRICS INCORPORATED
                                     PART II

                                OTHER INFORMATION


ITEM 4.      SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

A.  The annual meeting of shareholders was held on May 22, 1996.

B.  The following directors were elected to the board of directors:

             Vincent J. Coates
             Nathaniel Brenner
             Norman V. Coates
             John D. Heaton
             Clifford F. Smedley
             Kanegi Nagai

C.  The following matters were voted upon at the annual meeting:

                                                    For       Again    Abstain
                                                ---------     -----    -------
1.  To elect the following directors
    to serve for the ensuing year:

    Vincent J. Coates, Chairman                 5,872,118        0      2,450
    Nathaniel Brenner, Director                 5,872,118        0      2,450
    Norman V. Coates, Director                  5,872,118        0      2,450
    John D. Heaton, Director                    5,872,118        0      2,450
    Clifford F. Smedley, Director               5,872,118        0      2,450
    Kanegi Nagai, Director                      5,872,118        0      2,450

2.  To ratify the appointment of
    Deloitte & Touche LLP as independ-
    ent auditors for the fiscal
    year ending December 31, 1996.              5,871,518     2,750       300



ITEM 6.           EXHIBIT AND REPORTS ON FORM 8-K

A.  Exhibits

    None

B.  Reports on Form 8-K.

    None.


                                       10

<PAGE>


                            NANOMETRICS INCORPORATED

                                    SIGNATURE


    Pursuant to the  requirements  of the  Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

NANOMETRICS INCORPORATED
(Registrant)



 /s/ Vincent J. Coates
- ----------------------
Vincent J. Coates
Chairman and Chief Executive Officer




 /s/ Paul B. Nolan
- ------------------
Paul B. Nolan
Chief Financial Officer


Dated:   August 6, 1996

                                       11


<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                   1,000
       
<S>                             <C>
<PERIOD-TYPE>                                  6-MOS
<FISCAL-YEAR-END>                              Dec-31-1996
<PERIOD-START>                                 Apr-01-1996
<PERIOD-END>                                   Jun-30-1996
<CASH>                                         1,680
<SECURITIES>                                   6,072
<RECEIVABLES>                                  10,976
<ALLOWANCES>                                   378
<INVENTORY>                                    4,976
<CURRENT-ASSETS>                               25,476
<PP&E>                                         2,645
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 28,308
<CURRENT-LIABILITIES>                          5,111
<BONDS>                                        3,646
<COMMON>                                       11,156
                          0
                                    0
<OTHER-SE>                                     8,199
<TOTAL-LIABILITY-AND-EQUITY>                   28,308
<SALES>                                        11,545
<TOTAL-REVENUES>                               14,625
<CGS>                                          4,902
<TOTAL-COSTS>                                  6,950
<OTHER-EXPENSES>                               4,753
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                3,111
<INCOME-TAX>                                   1,316
<INCOME-CONTINUING>                            1,795
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   1,795
<EPS-PRIMARY>                                  .21
<EPS-DILUTED>                                  .21
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission